BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27913212)

  • 1. VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease.
    Guo X; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):552-559. PubMed ID: 27913212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease.
    Guo X; Sun X; Hu D; Wang YJ; Fujioka H; Vyas R; Chakrapani S; Joshi AU; Luo Y; Mochly-Rosen D; Qi X
    Nat Commun; 2016 Aug; 7():12646. PubMed ID: 27561680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.
    Fu Z; Liu F; Liu C; Jin B; Jiang Y; Tang M; Qi X; Guo X
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1428-1435. PubMed ID: 30802639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gossypol, a novel modulator of VCP, induces autophagic degradation of mutant huntingtin by promoting the formation of VCP/p97-LC3-mHTT complex.
    Li XJ; Zhang YY; Fu YH; Zhang H; Li HX; Li QF; Li HL; Tan RK; Jiang CX; Jiang W; Li ZX; Luo C; Lu BX; Dang YJ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1556-1566. PubMed ID: 33495516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBXD1 is a mitochondrial recruitment factor for p97/VCP and promotes mitophagy.
    Bento AC; Bippes CC; Kohler C; Hemion C; Frank S; Neutzner A
    Sci Rep; 2018 Aug; 8(1):12415. PubMed ID: 30120381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WIPI2 positively regulates mitophagy by promoting mitochondrial recruitment of VCP.
    Lu G; Tan HWS; Schmauck-Medina T; Wang L; Chen J; Cho YL; Chen K; Zhang JZ; He W; Wu Y; Xia D; Zhou J; Fang EF; Fang L; Liu W; Shen HM
    Autophagy; 2022 Dec; 18(12):2865-2879. PubMed ID: 35389758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A toxic mutant huntingtin species is resistant to selective autophagy.
    Fu Y; Wu P; Pan Y; Sun X; Yang H; Difiglia M; Lu B
    Nat Chem Biol; 2017 Nov; 13(11):1152-1154. PubMed ID: 28869595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
    Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
    Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective Mitochondrial Dynamics and Protein Degradation Pathways Underlie Cadmium-Induced Neurotoxicity and Cell Death in Huntington's Disease Striatal Cells.
    Kamitsuka PJ; Ghanem MM; Ziar R; McDonald SE; Thomas MG; Kwakye GF
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease.
    Qin Y; Chen L; Zhu W; Song J; Lin J; Li Y; Zhang J; Song X; Xing T; Guo T; Duan X; Zhang Y; Ruan E; Wang Q; Li B; Yang W; Yin P; Yan XX; Li S; Li XJ; Yang S
    Sci Adv; 2024 May; 10(20):eadl2036. PubMed ID: 38758800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered anterograde axonal transport of mitochondria in cultured striatal neurons of a knock-in mouse model of Huntington's disease.
    Wu C; Yin H; Fu S; Yoo H; Zhang M; Park H
    Biochem Biophys Res Commun; 2024 Jan; 691():149246. PubMed ID: 38029540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBXD8 mediates mitochondria-associated degradation to restrain apoptosis and mitophagy.
    Zheng J; Cao Y; Yang J; Jiang H
    EMBO Rep; 2022 Oct; 23(10):e54859. PubMed ID: 35979733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.
    Hunter JM; Lesort M; Johnson GV
    J Neurosci Res; 2007 Jun; 85(8):1774-88. PubMed ID: 17455294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protein quality control pathway regulated by linear ubiquitination.
    van Well EM; Bader V; Patra M; Sánchez-Vicente A; Meschede J; Furthmann N; Schnack C; Blusch A; Longworth J; Petrasch-Parwez E; Mori K; Arzberger T; Trümbach D; Angersbach L; Showkat C; Sehr DA; Berlemann LA; Goldmann P; Clement AM; Behl C; Woerner AC; Saft C; Wurst W; Haass C; Ellrichmann G; Gold R; Dittmar G; Hipp MS; Hartl FU; Tatzelt J; Winklhofer KF
    EMBO J; 2019 May; 38(9):. PubMed ID: 30886048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the proteostasis network in Huntington's disease.
    Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
    Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model mice.
    Kim W; Seo H
    Biochem Biophys Res Commun; 2014 Jan; 443(2):706-11. PubMed ID: 24333873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.
    Handley RR; Reid SJ; Brauning R; Maclean P; Mears ER; Fourie I; Patassini S; Cooper GJS; Rudiger SR; McLaughlan CJ; Verma PJ; Gusella JF; MacDonald ME; Waldvogel HJ; Bawden CS; Faull RLM; Snell RG
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11293-E11302. PubMed ID: 29229845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.